Abbott to Initiate First Study to Evaluate XIENCE(TM) V Everolimus Eluting Coronary Stent System in Treatment of Women With Cardiovascular Disease; First-of-its-Kind Study Designed to Learn More About Cardiovascular Disease in Women
PR Newswire, 2007Copyright PR Newswire Association LLC Feb 6, 2007
Digital Resources/Online E-Resources